Photo of Mark S. Chesnutt, M.D.

Mark S. Chesnutt M.D.

  • (503) 494-7660
    • Professor of Medicine, Division of Pulmonary and Critical Care Medicine School of Medicine
    • Director, Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence Interventional Radiology School of Medicine

Dr. Chesnutt is Director of the OHSU Hereditary Hemorrhagic Telangiectasia (HHT) Center of Excellence within the Charles T. Dotter Department of Interventional Radiology.

Dr. Chesnutt's clinical area of focus at OHSU is HHT and pulmonary arteriovenous fistulae (PAVF)/pulmonary arteriovenous malformations (PAVM).

Dr. Chesnutt serves as Director, Critical Care for the VA Portland Health Care System.

Read more

Areas of interest

  • HHT
  • Pulmonary arteriovenous fistula (PAVF)
  • Pulmonary arteriovenous malformation (PAVM)

Education

  • M.D., Oregon Health & Science University, Portland Oregon United States 1986
  • Internship:

    • Internal Medicine, University of California, San Francisco. 1986-1987
  • Residency:

    • Internal Medicine, University of California, San Francisco. 1987-1989
    • Chief Resident, Internal Medicine, University of California, San Francisco. 1989-1990
  • Fellowship:

    • Pulmonary & Critical Care Medicine, University of California, San Francisco. 1992-1996
  • Certifications:

    • Internal Medicine, 1989. Pulmonary Diseases, 1994, 2004, 2014. Critical Care Medicine, 1998, 2008

Edit profile